ArticleGut pathogens2025
Helicobacter hepaticus CdtB promoted brain impairment in BALB/c mice via gut-brain axis.
Article in Gut pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHelicobacter hepaticus infection has been linked to neurodegenerative diseases, but the underlying molecular mechanism is still unclear. In this study, we established an animal model of neurodegeneration via infecting BALB/c mice with wild-type H. hepaticus (WT) and CdtB-mutant (ΔCdtB) strains to investigate the influence of CdtB on the progression of cerebral injury.
methodsBALB/c mice were infected with either WT or ΔCdtB, and then were euthanized at 6- and 12- months post of infection (MPI). By means of histopathology and molecular biology techniques, we evaluated the colonization of H. hepaticus, colonic and cerebral pathologies, extracellular fibrillary β-amyloid (Aβ) aggregates, antigen responses, blood-brain-barrier (BBB) integrity, selected cytokines and proteins, as well as DNA damage.
resultsThe findings proved that H. hepaticus successfully colonized the intestines, whereas no bacterial DNA was observed in the brains of BALB/c mice. Nevertheless, CdtB antigen was identified in the brains of mice at sampling timepoint. During infection, CdtB exacerbated colonic and cerebral pathologies, compromised BBB integrity to amplify inflammatory responses in the brain, and modified the expression of critical neuronal proteins. Moreover, CdtB was found to induce DNA double-strand breaks (DSBs) and augment Aβ deposition in murine brains at 12 MPI.
conclusionsThese data indicated that H. hepaticus infection in BALB/c mice may serve as a novel model for studying neurodegenerative diseases. Furthermore, H. hepaticus CdtB has the potential to exacerbate both neurodegenerative conditions and inflammatory responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.